companydata.dkcompanydata.dk

PEAK BIOTECH A/S: Financial statements 2023

CVR: 28892152

Source: annual report 2023, Danish Business Authority

01/07/2022 – 30/06/2023

PEAK BIOTECH A/S (CVR 28892152) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 8,044,510 and a net result of DKK 3,374,405 compared with DKK 4,714,981 the year before. That is a decrease of 8.4% compared with the year before. Equity in the 2023 report amounted to DKK 13,577,035. The solvency ratio was 29.7%. The company had 4 employees in the financial year.

Gross Profit
DKK 8,044,510
Profit/Loss
DKK 3,374,405
Equity
DKK 13,577,035
Total Assets
DKK 45,754,673
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-8 mio.3.4 mio.13.6 mio.4
2022-8.8 mio.4.7 mio.10.7 mio.4
2021-9.1 mio.5.1 mio.11 mio.3
2020-10.4 mio.6.2 mio.10.4 mio.3
2019-10.5 mio.6.3 mio.10.3 mio.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

About PEAK BIOTECH A/S

PEAK BIOTECH A/S is a Danish company of the type Aktieselskab based in Kvistgård, founded in 2005. The company is registered under the industry Fremstilling af andre maskiner til specielle formål i.a.n.. The management consists of Kim Gejl Vind. The board consists of Jens Ulrik Damgaard (chair), Jacob Nøhr and Kim Gejl Vind. The company is owned by BIOTECH HOLDING ApS and PEAK HOLDING ApS. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 29,437,632 and a net result of DKK 21,861,113 compared with DKK 16,506,232 the year before. Equity in the 2025 report amounted to DKK 43,994,380.

Source: annual report 2025, Danish Business Authority